v3.26.1
SEGMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
SCHEDULE OF OPERATIONS BY REPORTABLE SEGMENT

Approximate information concerning the Company’s operations by reportable segment for the twelve months ended December 31, 2025 and 2024 is as follows. Segment information for prior periods presented has been recast to conform to the current-period segment presentation. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein:

 

Year Ended December 31, 2025  Product Packaging   Commercial Lending   Biotechnology   Securities   Corporate/
Other		   Total 
Revenue  $18,150,000   $45,000   $38,000   $2,524,000   $-   $20,757,000 
Cost of Revenue   16,619,000    20,000    424,000    5,844,000    19,000    22,926,000 
Gross profit (loss)   1,531,000    25,000    (386,000)   (3,320,000)   (19,000)   (2,169,000)
Operating expense   3,360,000    287,000    4,041,000    2,302,000    2,275,000    12,265,000 
Operating income (loss)   (1,829,000)   (262,000)   (4,427,000)   (5,622,000)   (2,294,000)   (14,434,000)
Other income (expense)   (143,000)   (236,000)   3,862,000    (11,904,000)   (4,633,000)   (13,054,000)
Net income (loss) from operations before taxes  $(1,972,000)  $(498,000)  $(565,000)  $(17,526,000)  $(6,727,000)  $(27,488,000)

 

Year Ended December 31, 2024  Product Packaging   Commercial Lending   Direct Marketing     Biotechnology   Securities   Corporate    Total 
Revenue  $16,107,000   $226,000   $  -     $-   $2,764,000   $-   $19,097,000 
Cost of revenue   15,230,000    712,000    

5,000

      42,000    7,550,000    -    23,539,000 
Gross profit (loss)   877,000    (486,000)   

(5,000

 )    (42,000)   (4,786,000)   -    (4,442,000)
Operating expense   3,029,000    402,000    

254,000

      28,929,000    2,759,000    2,781,000    38,154,000 
Operating income (loss)   (2,152,000)   (888,000)   

(259,000

 )    (28,971,000)   (7,545,000)   

(2,781,000

)   (42,596,000)
Other income (expense)   (159,000)   (1,186,000)   

81,000

      (3,784,000)   (6,822,000)   768,000    (11,102,000)
Net income (loss) from operations before taxes   (2,311,000)   (2,074,000)   

(178,000

 )    (32,755,000)   (14,367,000)   

(2,013,000

)   (53,698,000)
SCHEDULE OF DISAGGREGATION OF REVENUE

The following tables disaggregate our business segment revenues by major source:

 

Printed Products Revenue Information:

 

Twelve months ended December 31, 2025    
Packaging Printing and Fabrication  $17,710,000 
Commercial and Security Printing   376,000 
Real Property Rental Income   64,000 
Total Printed Products Revenue  $18,150,000 

 

Twelve months ended December 31, 2024    
Packaging Printing and Fabrication  $15,639,000 
Commercial and Security Printing   409,000 
Real Property Rental Income   59,000 
Total Printed Products Revenue  $16,107,000 

 

Commercial Lending Revenue Information:

 

Twelve months ended December 31, 2025    
Commercial lending  $45,000 
Total Commercial Lending Revenue  $45,000 

 

Twelve months ended December 31, 2024    
Commercial lending  $226,000 
Total Commercial Lending Revenue  $226,000 

 

Biotechnology Revenue Information:

 

Twelve months ended December 31, 2025    
Retail internet sales   38,000 
Total Biotechnology Revenue  $38,000 

 

Twelve months ended December 31, 2024     
Retail internet sales  $- 
Total Biotechnology Revenue  $- 

 

Securities Revenue Information:

 

Twelve months ended December 31, 2025    
Rental  $1,246,000 
Commission   1,278,000 
Total Securities Revenue  $2,524,000 

 

Twelve months ended December 31, 2024    
Rental  $1,792,000 
Commission   972,000 
Total Securities Revenue  $2,764,000